Prevention of Colorectal Cancer Through Multiomics Blood Testing

NCT ID: NCT04369053

Last Updated: 2025-12-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

48995 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-20

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Freenome is using a type of artificial intelligence, called machine learning, to identify patterns of cell-free biomarkers in blood to detect cancer early. The purpose of this prospective multi-center observational study is to validate a blood-based test for the detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Cancer Rectal Cancer Colon Neoplasm Colon Diseases Colon Lesion Colon Polyp Colorectal Cancer Polyp Adenoma Rectal Diseases Gastrointestinal Tract Cancers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Freenome test

Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled. Participants will undergo blood collection and will then complete a standard-of-care screening colonoscopy.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Single Group Assignment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 45-85 years of age
2. Willing to undergo a standard-of-care screening colonoscopy
3. Able and willing to provide a blood sample
4. Able and willing to sign informed consent

Exclusion Criteria

1. Known hereditary gastrointestinal cancer syndrome (for example, hereditary non-polyposis CRC syndrome (HNPCC) or Lynch syndrome, or familial adenomatous polyposis (FAP)
2. Personal history 2.1 CRC or colorectal adenoma 2.2 Inflammatory bowel disease (IBD), including chronic ulcerative colitis (CUC) and crohn's disease (CD) 2.3 Colonoscopy in the 9 years preceding enrollment 2.4 Stool DNA testing in the 2 years preceding enrollment 2.5 Symptoms of lower gastrointestinal tract disease warranting colonoscopic evaluation
3. A medical condition which, in the opinion of the Investigator, should preclude enrollment in the study
4. Participated or currently participating in a clinical research study in which an experimental medication has been administered during the 60 days up to and including the date of providing informed consent or may be administered through the time of the colonoscopy
Minimum Eligible Age

45 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Freenome Holdings Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aasma Shaukat, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

NYU Langone Health

Theodore R Levin, MD

Role: PRINCIPAL_INVESTIGATOR

Kaiser Permanente Division of Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central Alabama Research

Birmingham, Alabama, United States

Site Status

Alabama Oncology

Birmingham, Alabama, United States

Site Status

Clinical Research Associates

Huntsville, Alabama, United States

Site Status

Del Sol Research Management

Chandler, Arizona, United States

Site Status

Honor Health

Scottsdale, Arizona, United States

Site Status

Del Sol Research Management,

Tucson, Arizona, United States

Site Status

Preferred Research Partners

Little Rock, Arkansas, United States

Site Status

Highlands Oncology Group

Springdale, Arkansas, United States

Site Status

Precision Research Institute

Chula Vista, California, United States

Site Status

John Muir Health

Concord, California, United States

Site Status

Carbon Health

Corona, California, United States

Site Status

Miller Bioconnect

El Cajon, California, United States

Site Status

Gastroenterology and Liver Institute

Escondido, California, United States

Site Status

Women's Cancer Network

Fresno, California, United States

Site Status

San Diego Clinical Trials

La Mesa, California, United States

Site Status

Urology Alliance Clinical Research

Los Angeles, California, United States

Site Status

Science 37

Los Angeles, California, United States

Site Status

Mercy Cancer Center

Merced, California, United States

Site Status

Diverse Research Solutions

Oxnard, California, United States

Site Status

Pomona Valley Hospital Medical Center/Cancer Care Center

Pomona, California, United States

Site Status

St. Mary's Medical Center

San Francisco, California, United States

Site Status

Dominican Hospital Dignity Health

Santa Cruz, California, United States

Site Status

Stockton Hematology Oncology

Stockton, California, United States

Site Status

Torrance Memorial Physician Network - Cancer Care

Torrance, California, United States

Site Status

Gastroenterology Associates of Fairfield County

Bridgeport, Connecticut, United States

Site Status

Eastern CT Hematology and Oncology Associates

Norwich, Connecticut, United States

Site Status

Stamford Hospital

Stamford, Connecticut, United States

Site Status

RecioMed Clinical Research

Boynton Beach, Florida, United States

Site Status

Hillcrest Medical Research

DeLand, Florida, United States

Site Status

Universal Axon Clinical Research

Doral, Florida, United States

Site Status

Palmetto Research

Hialeah, Florida, United States

Site Status

Clinical Research of Homestead

Homestead, Florida, United States

Site Status

I.H.S Health, LLC

Kissimmee, Florida, United States

Site Status

Mid Florida Hematology & Oncology Center

Orange City, Florida, United States

Site Status

Advanced Gastroenterology Associates, LLC

Palm Harbor, Florida, United States

Site Status

Emerald Coast OBGYN

Panama City, Florida, United States

Site Status

Ascension Sacred Heart

Pensacola, Florida, United States

Site Status

United Medical Research

Port Orange, Florida, United States

Site Status

Charter Research

The Villages, Florida, United States

Site Status

Morehouse School of Medicine

Atlanta, Georgia, United States

Site Status

Crisp Regional Hospital

Cordele, Georgia, United States

Site Status

Cancer Center of Middle Georgia (QCCA)

Dublin, Georgia, United States

Site Status

SpeciCare, Inc

Gainesville, Georgia, United States

Site Status

Specicare

Gainesville, Georgia, United States

Site Status

University of Chicago

Chicago, Illinois, United States

Site Status

Walgreens

Deerfield, Illinois, United States

Site Status

Silver Cross Hospital and Medical centers

Orland Park, Illinois, United States

Site Status

Advocate Lutheran General Hospital

Park Ridge, Illinois, United States

Site Status

Rockford Gastroenterology

Rockford, Illinois, United States

Site Status

Northwest Oncology & Hematology

Rolling Meadows, Illinois, United States

Site Status

Springfield Clinic, LLP

Springfield, Illinois, United States

Site Status

Margaret Mary

Batesville, Indiana, United States

Site Status

Objective Health Network (Digestive Research Alliance of Michiana, LLC)

South Bend, Indiana, United States

Site Status

Aton Health

Leawood, Kansas, United States

Site Status

Ascension Via Christi Hospital, Wichita

Wichita, Kansas, United States

Site Status

Ascension Via Christi Wichita

Wichita, Kansas, United States

Site Status

Saint Joseph Cancer Center

Lexington, Kentucky, United States

Site Status

Delta Research Partners

Bastrop, Louisiana, United States

Site Status

New Orleans Research Institute

Metairie, Louisiana, United States

Site Status

Louisiana State University Health Sciences Center

Shreveport, Louisiana, United States

Site Status

Louisiana Research Center, LLC

Shreveport, Louisiana, United States

Site Status

Louisiana Research Center

Shreveport, Louisiana, United States

Site Status

Mercy Medical Center

Baltimore, Maryland, United States

Site Status

Ascension St. Agnes Hospital

Baltimore, Maryland, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Commonwealth Clinical Studies

Brockton, Massachusetts, United States

Site Status

Cape Cod Hospital

Hyannis, Massachusetts, United States

Site Status

University of Michigan

Ann Arbor, Michigan, United States

Site Status

Henry Ford Health

Detroit, Michigan, United States

Site Status

Ascension Providence Rochester Hospital

Rochester Hills, Michigan, United States

Site Status

Covenant HealthCare

Saginaw, Michigan, United States

Site Status

Allina Health Cancer Institute

Minneapolis, Minnesota, United States

Site Status

University of Minnesota, School of Public Health, Environmental Health Sciences

Minneapolis, Minnesota, United States

Site Status

Winona Health System

Winona, Minnesota, United States

Site Status

Memorial Hospital at Gulfport

Gulfport, Mississippi, United States

Site Status

Central Care Cancer Center

Bolivar, Missouri, United States

Site Status

Carroll County Memorial Hospital

Carrollton, Missouri, United States

Site Status

Hannibal Regional Hospital

Hannibal, Missouri, United States

Site Status

University Health Truman Medical Center

Kansas City, Missouri, United States

Site Status

North Kansas City Hospital

North Kansas City, Missouri, United States

Site Status

Billings Clinic

Billings, Montana, United States

Site Status

Logan Health Research

Kalispell, Montana, United States

Site Status

Quality Clinical Research

Omaha, Nebraska, United States

Site Status

Renown Regional Medical Center

Reno, Nevada, United States

Site Status

Cancer Care Specialists Reno

Reno, Nevada, United States

Site Status

Inspira Medical Center

Mullica Hill, New Jersey, United States

Site Status

St Joseph University

Paterson, New Jersey, United States

Site Status

Inspira Medical Center Vineland

Vineland, New Jersey, United States

Site Status

Our Lady of Lourdes Hospital

Binghamton, New York, United States

Site Status

NYU

New York, New York, United States

Site Status

NY Cancer & Blood Specialists

Port Jefferson Station, New York, United States

Site Status

White Plains Hospital

White Plains, New York, United States

Site Status

Asheville Gastroenterology Associates

Asheville, North Carolina, United States

Site Status

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Cumberland Research Associates

Fayetteville, North Carolina, United States

Site Status

Wakemed

Raleigh, North Carolina, United States

Site Status

Wake Research Associates

Raleigh, North Carolina, United States

Site Status

Iredell Memorial Hospital

Statesville, North Carolina, United States

Site Status

Trial Management Associates

Wilmington, North Carolina, United States

Site Status

Altru Health System

Grand Forks, North Dakota, United States

Site Status

Gabrail Cancer Center Research

Canton, Ohio, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Objective Health Network

Dayton, Ohio, United States

Site Status

Hightower Clinical Research

Oklahoma City, Oklahoma, United States

Site Status

Hightower Clinical

Oklahoma City, Oklahoma, United States

Site Status

St. Charles Health System, Inc

Bend, Oregon, United States

Site Status

Oregon Health & Science University

Portland, Oregon, United States

Site Status

Oregon Health and Science University

Portland, Oregon, United States

Site Status

Geisinger Bloomsburg Hospital

Bloomsburg, Pennsylvania, United States

Site Status

Doylestown Health

Doylestown, Pennsylvania, United States

Site Status

Clinical Research Associates of Central PA

DuBois, Pennsylvania, United States

Site Status

Pennsylvania Cancer Specialists & Research Institute

Gettysburg, Pennsylvania, United States

Site Status

US Digestive Health at Lancaster

Lancaster, Pennsylvania, United States

Site Status

Temple University

Philadelphia, Pennsylvania, United States

Site Status

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Site Status

Donald Guthrie Foundation

Sayre, Pennsylvania, United States

Site Status

Guthrie Medical Group

Sayre, Pennsylvania, United States

Site Status

USDH Clinical Research

Wyomissing, Pennsylvania, United States

Site Status

US Digestive Health at Wyomissing

Wyomissing, Pennsylvania, United States

Site Status

Cancer Care Associates of York (QCCA)

York, Pennsylvania, United States

Site Status

Medical University of South Carolina (MUSC)

Charleston, South Carolina, United States

Site Status

MUSC

Charleston, South Carolina, United States

Site Status

MacLeod Center for Cancer Treatment and Research

Florence, South Carolina, United States

Site Status

McLeod Health

Florence, South Carolina, United States

Site Status

Carolina Blood and Cancer Care Associates

Rock Hill, South Carolina, United States

Site Status

Circle Clinical Research

Pierre, South Dakota, United States

Site Status

Avera Cancer Institute

Sioux Falls, South Dakota, United States

Site Status

ObjectiveHealth, Inc

Franklin, Tennessee, United States

Site Status

The Jackson Clinic, PA

Jackson, Tennessee, United States

Site Status

The Jackson Clinic

Jackson, Tennessee, United States

Site Status

Elligo Health Research, Inc.

Austin, Texas, United States

Site Status

Christus Spohn Shoreline Hospital

Corpus Christi, Texas, United States

Site Status

Horizon Clinical Research Group

Houston, Texas, United States

Site Status

Oncology Consultants

Houston, Texas, United States

Site Status

The University of Texas M.D. Anderson Cancer Center

Houston, Texas, United States

Site Status

Christus Trinity Mother Frances Health System

Tyler, Texas, United States

Site Status

Advanced Research Institute

Ogden, Utah, United States

Site Status

Gastroenterology Associates of Tidewater

Chesapeake, Virginia, United States

Site Status

INOVA

Fairfax, Virginia, United States

Site Status

Verity Research Inc

Fairfax, Virginia, United States

Site Status

Centra Lynchburg Hematology Oncology

Lynchburg, Virginia, United States

Site Status

Digestive and Liver Disease Specialists

Norfolk, Virginia, United States

Site Status

Washington Gastroenterology

Bellevue, Washington, United States

Site Status

Northwest Medical Specialties (QCCA)

Tacoma, Washington, United States

Site Status

SSM Health-Dean Medical Group

Madison, Wisconsin, United States

Site Status

Ascension Columbia St. Mary's Wisconsin

Milwaukee, Wisconsin, United States

Site Status

Aurora St. Luke's Medical Center

Milwaukee, Wisconsin, United States

Site Status

Forzani and MacPhail Colon Cancer Screening Centre

Calgary, Alberta, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates United States Canada

References

Explore related publications, articles, or registry entries linked to this study.

Shaukat A, Burke CA, Chan AT, Grady WM, Gupta S, Katona BW, Ladabaum U, Liang PS, Liu JJ, Putcha G, Robertson DJ, Schoen RE, Meng Z, Piscitello A, Sun CK, Xu C, Lin CJ, Lee LC, Baldo L, Levin TR; PREEMPT CRC Investigators. Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer. JAMA. 2025 Jul 1;334(1):56-63. doi: 10.1001/jama.2025.7515.

Reference Type DERIVED
PMID: 40455622 (View on PubMed)

Kortlever TL, Ferlizza E, Lauriola M, Borrelli F, Porro A, Spaander MCW, Bossuyt PM, Ricciardiello L, Dekker E. Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes. Aliment Pharmacol Ther. 2025 Jun;61(12):1935-1943. doi: 10.1111/apt.70141. Epub 2025 Apr 10.

Reference Type DERIVED
PMID: 40207404 (View on PubMed)

Mills K, Figueroa F, Knight R, Ekpo E, Lee LC, Baldo L, Xu C, Wang S, Adelman RM, Pemu P, Levin T, Shaukat A, Liu JJ. Fact or Myth? Black Patients Do Not Want to Participate in Clinical Trials. Clin Transl Gastroenterol. 2025 Apr 1;16(4):e00826. doi: 10.14309/ctg.0000000000000826.

Reference Type DERIVED
PMID: 39878425 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FRNM-004

Identifier Type: -

Identifier Source: org_study_id